Illumina Body Map 2
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXM1 | hg19_v2_chr12_-_2986107_2986258 | 0.44 | 1.2e-02 | Click! |
TBL1XR1 | hg19_v2_chr3_-_176914998_176915021 | -0.11 | 5.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr14_+_22748980 Show fit | 13.14 |
ENST00000390465.2
|
T cell receptor alpha variable 38-2/delta variable 8 |
|
chr1_+_117297007 Show fit | 10.65 |
ENST00000369478.3
ENST00000369477.1 |
CD2 molecule |
|
chr2_+_102608306 Show fit | 10.52 |
ENST00000332549.3
|
interleukin 1 receptor, type II |
|
chr1_-_169680745 Show fit | 9.37 |
ENST00000236147.4
|
selectin L |
|
chr7_+_37888199 Show fit | 9.31 |
ENST00000199447.4
ENST00000455500.1 |
NME/NM23 family member 8 |
|
chr7_+_142045246 Show fit | 8.81 |
ENST00000390392.3
|
T cell receptor beta variable 4-2 |
|
chr14_+_22771851 Show fit | 8.74 |
ENST00000390466.1
|
T cell receptor alpha variable 39 |
|
chr14_+_22520762 Show fit | 8.57 |
ENST00000390449.3
|
T cell receptor alpha variable 21 |
|
chr14_+_22739823 Show fit | 8.43 |
ENST00000390464.2
|
T cell receptor alpha variable 38-1 |
|
chr14_+_22689792 Show fit | 8.42 |
ENST00000390462.1
|
T cell receptor alpha variable 35 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 166.6 | GO:0002377 | immunoglobulin production(GO:0002377) |
1.2 | 146.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
1.6 | 111.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 90.7 | GO:0043312 | neutrophil activation involved in immune response(GO:0002283) neutrophil degranulation(GO:0043312) |
0.5 | 50.1 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 45.1 | GO:0007283 | spermatogenesis(GO:0007283) |
0.3 | 45.0 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.2 | 39.0 | GO:0002250 | adaptive immune response(GO:0002250) |
0.4 | 31.0 | GO:0006968 | cellular defense response(GO:0006968) |
0.4 | 30.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 144.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 112.8 | GO:0005615 | extracellular space(GO:0005615) |
2.1 | 108.6 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.3 | 59.3 | GO:0072562 | blood microparticle(GO:0072562) |
1.5 | 55.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.4 | 54.9 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 38.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.3 | 35.6 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.4 | 35.4 | GO:0035580 | specific granule lumen(GO:0035580) |
0.7 | 31.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 272.9 | GO:0003823 | antigen binding(GO:0003823) |
1.8 | 119.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 50.2 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.4 | 38.5 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.2 | 31.7 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.5 | 31.2 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.7 | 29.6 | GO:0008009 | chemokine activity(GO:0008009) |
2.3 | 27.4 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.2 | 27.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 25.5 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 84.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 77.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.5 | 68.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.8 | 57.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 45.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.7 | 43.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.5 | 34.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.5 | 24.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.5 | 23.1 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.6 | 22.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 139.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.0 | 70.6 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 46.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
1.3 | 39.9 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 35.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 32.3 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.6 | 28.1 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.7 | 26.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.7 | 26.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.7 | 25.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |